Search Within

Saad Zafar Usmani

Formats
  1. Meeting Abstract (196)
  2. Journal Article (66)
  3. Review (14)
  4. Research Letter (9)
  5. Correspondence (4)
  6. Editorial (4)
  7. Guidelines (2)
  8. Book Section (1)
Groups
  1. Hematologic Malignancies, Division of (143)
  2. Department of Medicine (142)
  3. Center for Hematologic Malignancies (139)
  4. Myeloma (131)
  5. Graduate Medical Education (129)
  6. GME, Medicine (120)

More Groups

People
  1. Alexander Lesokhin (114)
  2. Kylee Maclachlan (109)
  3. Sham Mailankody (99)
  4. Urvi Shah (99)
  5. Carlyn Rose Tan (93)
  6. Malin Hultcrantz (91)

More People

Years
  1. 2025 (15)
  2. 2024 (75)
  3. 2023 (123)
  4. 2022 (83)
Publications
  1. Blood (86)
  2. Clinical Lymphoma, Myeloma and Leukemia (79)
  3. Journal of Clinical Oncology (30)
  4. Blood Cancer Journal (14)
  5. Blood Advances (13)
  6. Oncology Research and Treatment (7)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. Elsevier Inc. (91)
  3. American Society of Clinical Oncology (30)
  4. Nature Publishing Group (20)
  5. Elsevier Science, Inc. (10)
  6. S. Karger AG (7)

More Publishers

Results (296)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple myeloma
    Book Section

    Lu, S. X.; Rustad, E. H.; Usmani, S. Z.; Landgren, C. O.
    In Hoffman, R.; Benz, E. J. Jr; Silberstein, L. E.; Heslop, H. E.; Weitz, J. I.; Salama, M. E.; Abutalib, S. A. (Eds.) Hematology: Basic Principles and Practice. 8th ed (2023)

    Fulltext@MSK | Save
  • Heterogeneity in access and toxicity management of commercially available BCMA-directed CAR-T and Bispecific T-cell engager therapy among the international myeloma community
    Meeting Abstract

    Hassan, H.; Samur, M. K.; Cohen, A. D.; Moreau, P.; Otero, P. R.; Kumar, S. K.; Mateos, M. V.; Avigan, D.; Sperling, A. S.; Nadeem, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1 study of KTX-1001, an oral, first-in-class, selective MMSET inhibitor in patients with relapsed and refractory multiple myeloma
    Meeting Abstract

    Berdeja, J. G.; Dingli, D.; Lonial, S.; Yee, A. J.; Chung, A.; Gasparetto, C.; Bergsagel, P. L.; Roy, V.; Abdallah, A. O.; Thanendrarajan, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PROMMIS trial prospectively demonstrates the efficacy of SKY92 risk stratification in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Biran, N.; Dhakal, B.; Niesvizky, R.; Lentzsch, S.; McKay, J. T.; Vesole, D. H.; Nooka, A. K.; Paul, B.; Hari, P. N.; Stork-Sloots, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Safety and tolerability of Magrolimab combinations in patients with relapsed/refractory multiple myeloma (RRMM): Safety run-in results from a phase 2 Study
    Meeting Abstract

    Paul, B.; Minarík, J.; Cottini, F.; Gasparetto, C.; Khouri, J.; Gandhi, M.; Hillengass, J.; Levy, M.; Liedtke, M.; Manda, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Primary endpoint analysis from a response adaptive phase II clinical trial of carfilzomib, lenalidomide, dexamethasone plus daratumumab (KRd-Dara) in patients with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Bhutani, M.; Robinson, M.; Atrash, S.; Paul, B.; Pineda-Roman, M.; Foureau, D.; Varga, C.; Friend, R.; Begic, X.; Norek, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ibrutinib in combination with revlimid/dexamethasone (RD) in relapsed/refractory multiple myeloma (AFT-15)
    Meeting Abstract

    Efebera, Y.; Suman, V. J.; Dinner, S. N.; Rosko, A. E.; McKay, J. T.; Barth, P.; Hagen, P.; Usmani, S. Z.; Richardson, P. G.; Laubach, J. P.
    Blood (2023)

    Fulltext@MSK | Save
  • Cost per responder analysis of patients with lenalidomide-refractory multiple myeloma who received cilta-cel from the CARTITUDE-4 Trial
    Meeting Abstract

    Hansen, D. K.; Lu, X.; Castaneda, O.; Sorensen, S.; Usmani, S. Z.; Zhang, E.; Huo, S.; Jagannath, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Contemporary multiple myeloma treatment patterns among HCPs and concordance with expert recommendations: Analysis of an interactive online decision support tool
    Meeting Abstract

    Brandt, K. G.; Rosenthal, K.; Kumar, S. K.; Lentzsch, S.; Lonial, S.; Usmani, S. Z.; Quill, T. A.; Mikhael, J. R.
    Blood (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K. H.; Blaney, P.; Cirrincione, A.; Chu, T. R.; Poos, A. M.; Brown, E. E.; Manasanch, E. E.; Hoering, A.; Hou, L. M.; Gagler, D.; more...
    Blood (2023)

    Fulltext@MSK | Save